Literature DB >> 22043326

A case for more intensive systemic therapy for patients with locally advanced rectal cancer: even in the face of a pathologic complete response.

Max Vergo1, Al B Benson.   

Abstract

Entities:  

Year:  2011        PMID： 22043326      PMCID： PMC3201641          DOI： 10.1152/ajpcell.00650.2009

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  11 in total

1.  Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study.

Authors:  A K Chan; A O Wong; J Langevin; D Jenken; J Heine; D Buie; D R Johnson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

2.  Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.

Authors:  David P Ryan; Donna Niedzwiecki; Donna Hollis; Brent E Mediema; Scott Wadler; Joel E Tepper; Richard M Goldberg; Robert J Mayer
Journal:  J Clin Oncol       Date:  2006-04-24       Impact factor: 44.544

3.  Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.

Authors:  Prajnan Das; John M Skibber; Miguel A Rodriguez-Bigas; Barry W Feig; George J Chang; Paulo M Hoff; Cathy Eng; Robert A Wolff; Nora A Janjan; Marc E Delclos; Sunil Krishnan; Lawrence B Levy; Lee M Ellis; Christopher H Crane
Journal:  Am J Clin Oncol       Date:  2006-06       Impact factor: 2.339

4.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

5.  Chemotherapy with preoperative radiotherapy in rectal cancer.

Authors:  Jean-François Bosset; Laurence Collette; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Jean-Claude Ollier
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

6.  Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.

Authors:  N A Janjan; C Crane; B W Feig; K Cleary; R Dubrow; S Curley; J N Vauthey; P Lynch; L M Ellis; R Wolff; R Lenzi; J Abbruzzese; R Pazdur; P M Hoff; P Allen; T Brown; J Skibber
Journal:  Am J Clin Oncol       Date:  2001-04       Impact factor: 2.339

7.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

Authors:  Jean-Pierre Gérard; Thierry Conroy; Franck Bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

8.  A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer.

Authors:  C Aschele; M L Friso; S Pucciarelli; S Lonardi; L Sartor; G Fabris; E D L Urso; P Del Bianco; G Sotti; M Lise; S Monfardini
Journal:  Ann Oncol       Date:  2005-05-13       Impact factor: 32.976

9.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Authors:  Thierry André; Corrado Boni; Lamia Mounedji-Boudiaf; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Marta Zaninelli; Philip Clingan; John Bridgewater; Isabelle Tabah-Fisch; Aimery de Gramont
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

10.  Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.

Authors:  Laurence Collette; Jean-Francois Bosset; Marcel den Dulk; France Nguyen; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Marianne Piérart; Gilles Calais
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.